Method of treating type I diabetes using apolipoprotein A-IV
US9730980B2 · kind B2 · utility
0Cited by
2References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 25, 2013 |
| Grant date | Aug 15, 2017 |
| Priority date | — |
| Expiry date | Jul 25, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/775
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for treating type one diabetes mellitus in a subject in need thereof and pharmaceutical compositions for the treatment of type one diabetes mellitus are disclosed, including combination therapies with insulin. The methods include administering an effective amount of apolipoprotein A-IV to the subject having type I diabetes. The pharmaceutical composition includes apolipoprotein A-IV formulated for administration to a subject for the treatment of type one diabetes mellitus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.